GlaxoSmithKline PLC | Income Statement
Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
26,505
23,006
23,923
27,889
30,186
30,821
Cost of Goods Sold (COGS) incl. D&A
8,198
7,446
8,916
9,452
10,100
9,896
Gross Income
18,307
15,560
15,007
18,437
20,086
20,925
SG&A Expense
11,152
10,643
10,593
11,660
12,112
12,926
EBIT
7,155
-
4,414
6,777
7,974
7,999
Unusual Expense
2,010
2,069
4,713
5,169
4,293
2,979
Non Operating Income/Expense
2,126
703
11,405
942
466
382
Interest Expense
726
679
669
686
698
707
Pretax Income
6,604
2,938
10,512
1,934
3,512
4,769
Income Tax
1,019
137
2,154
877
1,356
754
Equity in Affiliates
43
30
14
5
13
31
Consolidated Net Income
5,628
2,831
8,372
1,062
2,169
4,046
Net Income
5,436
2,756
8,422
912
1,532
3,623
Net Income After Extraordinaries
5,436
2,756
8,422
912
1,532
3,623
Net Income Available to Common
5,436
2,756
8,422
912
1,532
3,623
EPS (Basic)
1.13
0.57
1.74
0.19
0.31
0.74
Basic Shares Outstanding
4,831
4,808
4,831
4,860
4,886
4,914
EPS (Diluted)
1.11
0.57
1.72
0.19
0.31
0.73
Diluted Shares Outstanding
4,919
4,865
4,888
4,909
4,941
4,971
EBITDA
8,569
6,401
6,044
8,551
9,896
9,855
Non-Operating Interest Income
59
66
75
70
63
74
Minority Interest Expense
192
75
50
150
637
423
About GlaxoSmithKline
View Profile
